GlassScriptPhysician profile
Nidhee Dubal
NPI 1093034290
$1,443.89
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $59.94 · 2021: $371 · 2022: $210 · 2023: $159 · 2024: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $342.15 | 2019-2024 | Grafix Pl, Oasis |
| Paratek Pharmaceuticals, INC. | $248.38 | 2021-2024 | Nuzyra |
| Kci USA, INC. | $133.99 | 2019 | |
| Organogenesis INC. | $116.48 | 2019-2024 | Affinity |
| Stryker Corporation | $67.57 | 2021-2022 | |
| Averitas Pharma INC. | $57.90 | 2023-2024 | Qutenza |
| Horizon Therapeutics Plc | $55.77 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $50.02 | 2019 | |
| Abbvie INC. | $48.95 | 2022-2023 | Dalvance |
| Bioventus LLC | $46.80 | 2023 | Exogen Ultrasound Bone Healing System |
| Reprise Biomedical, INC. | $46.41 | 2024 | Miro3d |
| Kerecis Limited | $42.74 | 2019-2021 | |
| Sandoz INC. | $37.11 | 2019 | |
| Solventum Corporation | $31.93 | 2024 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Medtronic, INC. | $31.16 | 2023 | Intellis Adaptivestim |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $25.16 | 2020-2021 | |
| Advanced Oxygen Therapy INC. | $17.85 | 2022 | |
| Wright Medical Technology, INC. | $16.82 | 2020 | |
| Misonix INC | $15.12 | 2021 | |
| Melinta Therapeutics, LLC | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nidhee Dubal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.